Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency

Annals of Allergy Asthma & Immunology(2023)10.1016/j.anai.2023.01.025Source: DataRank Database

Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency is a research paper published in Annals of Allergy Asthma & Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.09)OA: bronzeTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Michelle Premazzi Papa ORCID,Marta Sanz ORCID,Samuel Nicholes,Carissa S. Holmberg ORCID,Alberto Bosque ORCID

Live enrichment

PubMed:36736722 PMC:PMC9891791 OpenAlex:https://openalex.org/W4318769311

NIAID NIH HHS

Grant: R01 AI152770

NIAID NIH HHS

Grant: P30 AI117970

NIAID NIH HHS

Grant: R01 AI125097

NIAID NIH HHS

Grant: R21 AI140788

NIAID NIH HHS

Grant: R21 AI157864

NIAID NIH HHS

Grant: T32 AI158105

National Institutes of Health

Grant: 7R01AI125097-05

Peripheral and tissue-resident gamm/delta T cells in HIV latency

National Institutes of Health

Grant: 1R01AI152770-01A1

Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies

National Institutes of Health

Grant: 1R21AI140788-01A1

Effects of boosting mucosal immunity by microbiota manipulation on B cell responses to HIV-1 vaccine

National Institutes of Health

Grant: 1R21AI157864-01A1

Allogeneic cytotoxic gammadelta T cells for HIV cure immunotherapy

National Institutes of Health

Grant: 3P30AI117970-10S4

District of Columbia Center for AIDS Research

FWCI

0.09

Citation Percentile

0.4%

Citation Trend

2026

bronzeLicense: Elsevier TDM

journalhttp://www.annallergy.org/article/S1081120623000777/pdf

publisherhttp://www.annallergy.org/article/S1081120623000777/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1081120623000777?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1081120623000777?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.anai.2023.01.025

Fields of Study

Immunodeficiency and Autoimmune DisordersComplement system in diseasesImmune responses and vaccinations0301 basic medicine0303 health sciences03 medical and health sciencesHumansCommon Variable ImmunodeficiencyCOVID-19COVID-19 VaccinesLeukocytes, MononuclearVaccinationImmunoglobulin GPrimary Immunodeficiency DiseasesGlycoproteins

MeSH Terms

Primary Immunodeficiency DiseasesCOVID-19COVID-19 VaccinesGlycoproteinsHumansImmunoglobulin GLeukocytes, MononuclearVaccinationCommon Variable Immunodeficiency

Keywords

Common variable immunodeficiencyImmunologyAntibodyMedicineVaccinationAntibody titerCD8AntigenTiterCOVID-19 VaccinesImmunoglobulin GPrimary Immunodeficiency DiseasesLeukocytes, MononuclearHumansCOVID-19Original ArticleGlycoproteins

Sustainable Development Goals

SDG 0: Good health and well-being